HSP90AA1 and cancer: HSP90 inhibitors, such as herbimycin A, radicicol, GA and its derivatives, characterized as effective anti-cancer therapeutics and several of which now in phase I and II clinical trials[33,34], have been shown to have strong antiviral activity.